Evidence map›Paper›PMID 41249718›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Clinical potential of [

Jan-Michael Werner, Maximilian J Mair, Michael M Wollring, Enio Barci, Isabelle Stetter, Hannah C Puhr, Caroline Tscherpel, Gabriele Stoffels, Johannes A Hainfellner, Anna S Berghoff and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Jan-Michael WernerDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-7147-4594
Maximilian J MairDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6537-3874
Michael M WollringDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0003-2177-6708
Enio BarciDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Isabelle StetterDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0009-0007-1732-5759
Hannah C PuhrDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-7203-8732
Caroline TscherpelDepartment of Neurology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Gabriele StoffelsInstitute of Neuroscience and Medicine (INM-3, INM-4), Research Center Juelich, Juelich, Germany.
Johannes A HainfellnerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
Anna S BerghoffDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9379-6797
Vincent Sunder-PlassmannDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Georg WidhalmDepartment of Neurosurgery, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6014-0273
Franziska EckertDepartment of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Gregor KasprianDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Thomas S NakuzDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Alexander BeckCenter for Neuropathology and Prion Research, LMU University Hospital, LMU Munich, Munich, Germany.
Patrick N HarterCenter for Neuropathology and Prion Research, LMU University Hospital, LMU Munich, Munich, Germany.
Louisa von BaumgartenGerman Cancer Consortium (DKTK), University Hospital, Partnersite LMU Munich, Munich, Germany.ORCID 0000-0002-6634-0927
Niklas ThonDepartment of Neurosurgery, LMU University Hospital, LMU Munich, Munich, Germany.
Stephan SchöneckerDepartment Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Robert ForbrigInstitute of Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany.
Felix M MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0002-7212-6521
Philipp LohmannInstitute of Neuroscience and Medicine (INM-3, INM-4), Research Center Juelich, Juelich, Germany.ORCID 0000-0002-5360-046X
Gereon R FinkDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-8230-1856
Karl-Josef LangenInstitute of Neuroscience and Medicine (INM-3, INM-4), Research Center Juelich, Juelich, Germany.ORCID 0000-0003-1101-5075
Norbert GalldiksDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-2485-1796
Nathalie L AlbertDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-0953-7624
Matthias PreusserDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. matthias.preusser@meduniwien.ac.at.ORCID 0000-0003-3541-2315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the clinical potential of O-(2-[

methodsWe retrospectively identified adult CAG patients who underwent [

resultsWe evaluated 79 [

conclusions[

Indexed as

AstrocytomaBrain NeoplasmsPositron-Emission TomographyTyrosineAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesYoung Adult(18F)fluoroethyltyrosineO-(2-fluoroethyl)tyrosineTyrosineBRAFPET RANO 1.0Response assessmentTreatment-related changes

Identifiers

PMID41249718
PMCPMC12920724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.